Israel-based neurovascular device developer Perflow Medical said it closed a $12 million round of financing to help support its Stream dynamic neuro-thrombectomy net designed for treating acute ischemic stroke. Funding from the round will support the European commercialization of the company’s first product, the Stream Net device, and a 510(k) submission to the FDA in […]
Blood Management
Stryker wins expanded FDA indications for Trevo thrombectomy device
Stryker (NYSE:SYK) said today it won expanded FDA indications for its Trevo thrombectomy device, now cleared as a front-line treatment for acute ischemic stroke patients for up to 24 hours from symptom onset. The expanded indication lifts the previously cleared treatment window by 18 hours, according to the Kalamazoo, Mich.-based company. “The 24-hour indication opens the […]
17 black innovators who made medtech better
From cardiology to endoscopy to blood transfusion, African Americans have played an important role as innovators in the history of medicine and medtech. To help mark African American History Month, here’s a look at some of their greatest achievements. Here are 17 black innovators who have made discoveries and invented devices to make medtech better. […]
Penumbra touts non-inferiority in Compass aspiration thrombectomy trial
Penumbra (NYSE:PEN) late last month released results from the Compass trial of its aspiration thrombectomy system designed to treat acute ischemic stroke, touting that the system was shown to be non-inferior to stent retrievers. Results from the trial were presented at the International Stroke Conference, the Alameda, Calif.-based company said. Investigators in the trial aimed to […]
J&J’s Cerenovus launches Galaxy G3 mini embolic coil, touts Arise II Embotrap study data
Johnson & Johnson‘s (NYSE:JNJ) Cerenovus division this week announced the launch of its Galaxy G3 Mini embolic coil and released data from a study of its Embotrap device designed to remove clots from the brain following ischemic stroke. The Galaxy G3 Mini coils are designed to be approximately 25% softer than the Galaxy G3 xsft […]
Laminate Medical launches study of VasQ hemodialysis fistula device
Laminate Medical Technologies said today it launched a pivotal, FDA-cleared trial of its VasQ implanted blood vessel device designed for patients requiring arteriovenous fistulas as vascular access for hemodialysis. The Israel-based company’s VasQ device is designed to aid kidney failure patients in need of dialysis by providing external support to reduce fistula failure. The device regulates […]
Abbott wins CE Mark for Alinity h-series hematology system
Abbott (NYSE:ABT) said today it won CE Mark approval in the European Union for its Alinity h-series integrated hematology testing system and that it launched the device in the associated regions. The newly cleared system features integration of the Alinity hq system with the Alinity hs slide marker and stainer module. The company touts the system […]
Biom’Up wins FDA PMA nod for Hemoblast Bellows surgical hemostatic
Biom’Up said today it won FDA premarket approval for its Hemoblast Bellows hemostatic product designed to control bleeding during surgeries including cardiac, general and orthopedic procedures. The Paris-based company’s flagship Hemoblast Bellows product is a ready-to-use hemostatic solution that is usable several times during surgery to reduce bleeding. Approval of the hemostatic came based on […]
Singapore vascular access dev Advent Access raises $2m in pre-Series A
Singapore-based vascular access dev Advent Access has raised $1.9 million (SGD $2.6 million) in a pre-Series A financing round to support its av-Guardian technology designed to create vascular access for dialysis patients. The funding round was led by Accuron MedTech, which the company touted as the largest medical device company in southeast Asia. The investment […]
CytoSorbents wins German gov’t funding for CytoSorb endocarditis trial
CytoSorbents (OTC:CTSO) said this week it won funding from the German Federal Ministry of Education and Research for a randomized controlled trial exploring the use of its CytoSorb blood purification technology for treating infective endocarditis. The newly funded randomized, controlled, multi-center Remove trial aims to enroll 250 patients to explore the safety and efficacy of intraoperative […]
GE’s Drawbridge Health inks collaborative deal with Thorne Research
GE Healthcare‘s (NYSE:GE) newly launched blood collection business Drawbridge Health said today it inked a strategic collaboration deal with Thorne Research to develop solutions for improving blood collection for health and wellness customers. Through the deal, Thorne Research and subsidiary WellnessFX will gain access to Drawbridge Health’s proprietary blood draw integration, collection and sample stabilization […]